EdgarLookup
SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company
Carisma Therapeutics Inc.
Filed
January 5, 2023
Accession Number
0000921895-23-000056
View Document ↗ View on SEC.gov ↗